LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 11 of 483
Next
>>
>
251 to 275 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PHA-665752	0.04	uM	LJP5	3	F18	72	hr	1334	4276	3970	1.0768	1.1157
BT-20	Dovitinib	0.04	uM	LJP5	3	E24	72	hr	1334	3357	3970	0.8454	0.7671
BT-20	Enzastaurin	0.04	uM	LJP5	1	D18	72	hr	1334	3324	3970	0.8371	0.7546
BT-20	Mitoxantrone	0.12	uM	LJP5	1	C23	72	hr	1334	1029	3970	0.2591	-0.1160
BT-20	Enzastaurin	0.04	uM	LJP5	2	D18	72	hr	1334	3540	3970	0.8915	0.8365
BT-20	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1334	4447	3970	1.1199	1.1806
BT-20	Enzastaurin	0.04	uM	LJP5	3	D18	72	hr	1334	4357	3970	1.0972	1.1465
BT-20	PLX-4720	0.04	uM	LJP5	1	K06	72	hr	1334	4016	3970	1.0114	1.0171
BT-20	PLX-4720	0.04	uM	LJP5	2	K06	72	hr	1334	4205	3970	1.0590	1.0888
BT-20	PLX-4720	0.04	uM	LJP5	3	K06	72	hr	1334	4206	3970	1.0592	1.0892
BT-20	Erlotinib	0.04	uM	LJP5	2	M24	72	hr	1334	3481	3970	0.8766	0.8142
BT-20	Ruxolitinib	0.04	uM	LJP5	3	O18	72	hr	1334	4116	3970	1.0365	1.0550
BT-20	Erlotinib	0.04	uM	LJP5	3	M24	72	hr	1334	3883	3970	0.9779	0.9667
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1334	3267	3970	0.8227	0.7330
BT-20	Foretinib	0.04	uM	LJP5	1	H12	72	hr	1334	3769	3970	0.9492	0.9234
BT-20	SU11274	0.04	uM	LJP5	2	J12	72	hr	1334	4162	3970	1.0481	1.0725
BT-20	Radicicol	0.04	uM	LJP5	1	K12	72	hr	1334	3320	3970	0.8361	0.7531
BT-20	Radicicol	0.04	uM	LJP5	2	K12	72	hr	1334	3358	3970	0.8457	0.7675
BT-20	Radicicol	0.04	uM	LJP5	3	K12	72	hr	1334	3410	3970	0.8588	0.7872
BT-20	Foretinib	0.04	uM	LJP5	3	H12	72	hr	1334	4154	3970	1.0461	1.0695
BT-20	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1334	3923	3970	0.9879	0.9818
BT-20	TGX221	0.04	uM	LJP5	3	H24	72	hr	1334	3720	3970	0.9368	0.9048
BT-20	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1334	4134	3970	1.0411	1.0619
BT-20	Nilotinib	0.12	uM	LJP5	2	N17	72	hr	1334	4290	3970	1.0804	1.1210
BT-20	Nilotinib	0.12	uM	LJP5	1	N17	72	hr	1334	4177	3970	1.0519	1.0782

|<
<<
Previous
Page 11 of 483
Next
>>
>
251 to 275 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)